SHPA announces PharmCare Conference 2023
Friday, 21 October, 2022
has announced a new conference for accredited, embedded and general practice pharmacists leading patient-centred care. The conference will take聽place over two days, 2鈥4 March 2023, in Hobart, Tasmania.
SHPA President Peter Fowler said the new is shaped by the SHPA鈥檚 Specialty Practice networks, in response to growing demand for clinical pharmacist education focused on crucial primary aged care settings.
鈥淧harmCare Conference 2023 is about improving communications, connections and care, and centralising the patient experience through the practice of accredited, embedded and GP pharmacists, in existing and emerging roles.鈥
The comprehensive two-day program will include key clinical updates, focused skills development, a sweeping state of the nation and plentiful moments to network, connect and enjoy the sights and tastes of harbourside Hobart; preliminary program details to come.
SHPA Chief Executive Kristin Michaels said SHPA reaffirms its commitment to supporting the expertise of accredited pharmacists.
鈥淚n December we plan to launch two education pathways to support the clinical expertise of this growing cohort 鈥 one for pharmacists moving into new embedded pharmacist roles in residential aged care and a second for practitioners becoming accredited pharmacists.
鈥淣ext year we will extend our national awards program, establishing new honours for established and emerging accredited pharmacists, plus a third honour for outstanding practice in residential aged care.
Michaels said that the SHPA will continue to advocate for the crucial role pharmacists play in upholding quality use of medicines and medication safety for patients who are at risk of medication-related harm and hospitalisation.
WA's Health Support Services appoints Giles Nunis CEO
In WA, Health Support Services has appointed Giles Nunis its new Chief Executive Officer,...
The ACCC institutes Federal Court proceedings against Bupa
The ACCC has instituted Federal Court proceedings against Bupa for breaches of the Australian...
Whiteley opens $25m Human Therapeutics Plant in the Hunter
Human Therapeutics Plant, a new $25 million facility for the manufacture of alcohol-based hand...